Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
296.92
-0.58 (-0.19%)
Jul 28, 2026, 2:54 PM EDT - Market open
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 153.56 | 124.45 | -4.03 | 52.15 | -33.36 | 57.14 |
Depreciation & Amortization | 33.22 | 33.78 | 35.24 | 36.52 | 51.53 | 51.07 |
Stock-Based Compensation | 49.61 | 46.85 | 41.09 | 25.74 | 60.29 | 38.78 |
Other Adjustments | -22.97 | -143.05 | 5.4 | -30.44 | -6.29 | -11.19 |
Change in Receivables | -14.75 | -21.74 | -6.46 | -2.6 | 55.32 | -28.62 |
Changes in Inventories | 1.35 | 4.99 | 9.62 | -10.87 | 12.06 | -0.43 |
Changes in Accounts Payable | 10.75 | 5.88 | 13.9 | -4.7 | -3.34 | 2.81 |
Changes in Income Taxes Payable | 3.03 | 2.67 | 2.31 | -1.78 | 1.58 | -3.98 |
Changes in Unearned Revenue | -0.29 | -0.58 | -1.31 | 0.42 | -6.28 | -17.87 |
Changes in Other Operating Activities | -1.7 | -3.89 | 1.29 | -14.87 | 6.34 | -8.93 |
Operating Cash Flow | 123.5 | 49.36 | 97.05 | 49.58 | 137.85 | 78.8 |
Operating Cash Flow Growth | 133.58% | -49.14% | 95.75% | -64.04% | 74.94% | 44.36% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.47 | -0.45 | -1.82 | -3.52 | -17.92 | -8.76 |
Purchases of Investments | -895.69 | -740.81 | -231.58 | -142.01 | -51.98 | -181.33 |
Proceeds from Sale of Investments | 427.16 | 377.28 | 262.5 | 194.17 | 234.39 | 221.34 |
Cash Acquisitions | - | - | -167 | -10.41 | - | - |
Other Investing Activities | 5.48 | -6.22 | -12.89 | -49.91 | -0.87 | -0.73 |
Investing Cash Flow | -476.56 | -377.32 | -143.66 | -11.68 | 163.62 | 30.52 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 460 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | -76.85 | -260.95 | -155.76 |
Net Long-Term Debt Issued (Repaid) | - | 460 | - | -76.85 | -260.95 | -155.76 |
Issuance of Common Stock | 50.93 | 121.8 | 102.73 | 22.45 | 3.43 | 52.7 |
Repurchase of Common Stock | -22.44 | -137.85 | -5.14 | -4.55 | -8.24 | -24.46 |
Net Common Stock Issued (Repurchased) | 28.5 | -16.05 | 97.59 | 17.9 | -4.8 | 28.24 |
Other Financing Activities | -15.53 | -15.73 | -0.45 | -0.99 | -10.24 | -10.24 |
Financing Cash Flow | 418.84 | 428.22 | 97.14 | -59.95 | -275.99 | -137.76 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 1.26 | 2.36 | -1.17 | - | - | - |
Net Cash Flow | 67.11 | 102.62 | 49.35 | -22.05 | 25.48 | -28.44 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 123.03 | 48.91 | 95.23 | 46.06 | 119.93 | 70.04 |
Free Cash Flow Growth | 141.52% | -48.64% | 106.76% | -61.60% | 71.23% | 39.72% |
FCF Margin | 44.82% | 18.24% | 56.98% | 35.07% | 61.11% | 29.00% |
Free Cash Flow Per Share | 6.03 | 2.41 | 5.21 | 2.59 | 7.11 | 4.06 |
Levered Free Cash Flow | 199.45 | 626.85 | 55.2 | -23.5 | -250.34 | -84.7 |
Unlevered Free Cash Flow | 162.15 | 91.82 | 16.98 | 12.43 | 50.46 | 109.72 |